Market Research Logo

Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products


Attention: There is an updated edition available for this report.

The global blood industry has experienced strong growth in recent years and although this brisk expansion will slow somewhat as products continue to mature and pricing pressures increase, growth will remain solid though 2017 as a result of aging populations in the U.S., Europe and Japan; ongoing technology advancements/new product introductions and indications; expansion of health coverage in the U.S. via health care reform; and continued strong promotion of blood donation by collection agencies.

Kalorama Information's Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products provides an analysis of all the key market segments involved in this industry, including products, equipment and testing.

A variety of infectious agents can be present in blood, including viruses (e.g., HIV-1, hepatitis B and C, HTLV, West Nile virus), bacteria, protozoans, Chagas disease, Lyme Disease and prions (e.g., the agent of variant Crueutzfeldt-Jakob disease, which is the human form of mad cow disease). As of 2013, the main residual risk is due to hepatitis B virus - ranging from 10 in Spain to 1.6 per million donations in France and Germany – although other conditions such as variant Creutzfeldt-Jakob disease (vCJD) or HIV may pose high risk in certain regions.

Testing markets covered include:

  • Blood Banking and Plasmapheresis Testing
  • Blood Typing
  • Human Immunodeficiency Virus (HIV) Testing
  • Hepatitis A Virus Testing
  • Hepatitis B Virus Testing
  • Hepatitis C Virus Testing
  • Human T-Cell Leukemia Virus Testing
  • West Nile Virus Testing
  • Other Safety Testing
The market for human blood and blood components continues to expand as a result of the growing and aging populations, particularly in the developed nations. Aside from RBCs, other blood products are also often required in such procedures. Organ transplants, for example, typically require  platelets,  cryoprecipitate and  frozen plasma.  Synthetic blood products are not derived from human blood, but instead represent oxygen-carrying volume-replacement solutions. Although efforts are underway to develop artificial cells or to culture red blood cells (RBCs) from stem cells, present synthetic blood products do not contain cells, antibodies, coagulation factors, or any of the other myriad components of blood itself.  One of the primary reasons for their development is to ease the projected shortage in the blood supply. 

  Blood products covered in the report include:
  • Red Blood Cells (RBCs)
  • Immunoglobulins
  • Albumin
  • Other Plasma Products
  • Synthetic HBOC and PFC Agents
  • Recombinant Factors
Donated blood is collected by specialized collection centers. After collection, whole blood is separated into its three main components: red blood cells (RBCs), platelets, and plasma. Sometimes a fourth component called cryoprecipitate (a fraction of plasma highly concentrated in some clotting factors such as Factor VIII or antihemophilic factor, fibrinogen, and von Willebrand factor) is also generated. Several different types of organizations currently collect blood. While most operate on a not for profit basis, some pay donors.

Blood equipment revenues and forecasts are provided for:
  • Blood Collection Equipment
  • Automated Blood Collection Equipment
In addition to complete market data, including forecasts to 2017, the study reports:
  • Product demand estimates by region
  • Collection and transfusion estimates
  • High-blood-loss procedure estimates
  • Product pricing
  • Reimbursement rates
  • Epidemiology of key conditions requiring blood products
  • Products on the market and in development
The report also provides discussions of the key trends, as well as the regulatory, business, and clinical challenges facing the various sectors; profiles of 23 major players in the industry are included.

The report profiles key companies in the industry, including:
  • AABB
  • Abbott Laboratories
  • America’s Blood Centers
  • American Red Cross
  • Baxter International
  • Bio-Rad Laboratories
  • BioTime Inc.
  • Gen-Probe Inc. /Hologic
  • Fenwal/Fresenius Kabi
  • Grifols Biologicals, Inc.
  • Novartis Diagnostics
  • Novo Nordisk A/S
  • OPK BioTech
  • Oxygen Biotherapeutics
  • Perftoran
  • Roche
  • Sanguine Corp.
Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2007 to 2010 period and forecasts are provided through 2017.  Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives were conducted to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis.

Specifically excluded from this report are blood testing products not used primarily for blood donation and collection. For example, tests for blood banking represent about 12% of all immunoassay infectious disease tests (which include tests for HIV, hepatitis B and C and syphilis) and about one quarter of all nucleic acid tests (which include assays for West Nile Virus, HIV and hepatitis C).


  • Executive Summary
    • THE GLOBALBLOOD INDUSTRY
    • SCOPEAND METHODOLOGY
    • OVERVIEW
    • BLOOD COLLECTION
    • BLOOD TYPING AND TESTING FOR DISEASES
      • Blood Testing
    • BLOOD STORAGE AND PROCESSING
    • BLOOD TRANSFUSIONS
    • BLOODMANAGEMENT AND SAFETY ISSUES
    • SYNTHETIC BLOOD PRODUCTS
    • BLOOD PRODUCTS MARKET
      • Table Global Blood Products Market, 2012
    • BLOOD TESTING AND TYPING PRODUCTS MARKET
    • PLASMA AND BLOOD COLLECTION EQUIPMENT MARKET
      • Table Total Global Market for Blood Collection Equipment: 2007 - 2017
    • SYNTHETIC BLOOD PRODUCTS MARKET
      • Table Recombinant Factor and High Blood Loss Market: 2012 - 2017
  • Overview
    • THE GLOBAL BLOOD INDUSTRY
    • HISTORY OF THE BLOOD INDUSTRY
      • United States
      • Europe
      • Asia
    • CURRENT BLOOD INDUSTRY ISSUES
      • Effects of the Economy
      • Changes from Health Care Reform
      • Demographic Shifts
    • BLOOD AND ITS COMPONENTS
      • Red Blood Cells (Erythrocytes)
      • White Blood Cells (Leukocytes)
      • Platelets
      • Plasma
    • IMMUNOGLOBULIN PRODUCTS
    • BLOOD TRANSFUSIONS
      • Diseases Contracted from Blood Transfusions and Related Identification Testing
    • EFFORTS TO CREATE A VIRUS-FREE BLOOD SUPPLY
      • Plasma Treatment
        • Table Viral Inactivation Methods for Viruses Found in Platelets
      • Red Blood Cell Treatments
        • Table Viral Inactivation Methods for Viruses Found in Red Blood Cells
    • SYNTHETIC BLOOD PRODUCTS
      • Blood Volume Expanders
      • Hemoglobin Based Oxygen Carriers
      • Perflurocarbon (PFC) Based Blood Products
      • Factor Products for Hemophilia A
      • Synthetic Platelets
  • The Blood Management System: Blood Collection, Processing and Use
    • BLOOD COLLECTION
    • ORGANIZATIONS COLLECTING BLOOD
      • Not For-Profit Blood Collection
      • Red Cross
      • Community Blood Banks
      • Hospitals
      • Other Blood Collection Sites
      • For-Profit Blood Collection
      • National Donor Deferral Registry
    • DONOR DONATION DEMOGRAPHICS
    • DONOR RECRUITMENT
    • BLOOD SCREENING AND EVALUATION
    • METHODS FOR COLLECTING BLOOD FROM DONORS
      • Manual Blood Collection
      • Automated Blood Collection
      • Leukopheresis
      • Red Blood Cell Apheresis
    • CORD BLOOD COLLECTION
    • PLASMA COLLECTION
      • Plasma Fractionators
      • Distributors/Brokers
    • BLOOD TYPING AND TESTING FOR DISEASES
      • Blood Typing
        • Table Basic Blood Types
        • Table Blood Transfusion Compatibility
      • Methods of Blood Typing
    • BLOOD TESTING
      • Nucleic Acid Amplification Testing (NAT)
      • Polymerase Chain Reaction (PCR) Amplification
      • CBER Licensed PCR Screening Tests
      • Immunoassay
      • Enzyme-Linked Immunosorbent Assay
      • Costs and Other Barriers
      • Blood Storage
    • BLOOD PROCESSING
      • Cohn Fractionation
      • Newer Fractionation Methods
        • Table Plasma Proteins of Therapeutic Interest
      • Advanced Fractionation Methods
    • BLOOD TRANSFUSIONS
    • TESTING BEFORE TRANSFUSION
      • Coombs Test
      • Manual Cross-Match Techniques
      • Major Cross-Match
      • Minor Cross-Match
      • Antibody Screen
    • TYPES OF TRANSFUSIONS
      • Whole Blood
      • Packed Red Blood Cells
      • Platelets
      • Leukocytes
      • Fresh Frozen Plasma (FFP)
      • Cryoprecipitate
      • Immune Serum Globulin/IMIG/IGIV
      • Factor IX and Factor IX Complex
      • C1 Inhibitor
      • Fibrin/Thrombin
      • Therapeutic Apheresis
    • BLOODMANAGEMENT ISSUES
      • Availability
    • SAFETY ISSUES
      • Reducing Blood Typing Errors
      • Improving Donor Screening
      • Improving Viral Screening
      • Increasing Repeat Donation Rates
      • Enhancing Viral Inactivation Processes
      • Increasing Voluntary Donation
      • Preventing Bacterial Infections
      • Biovigilence
      • Other Safety Precautions
  • The Human Blood and Blood Products Market
    • DRIVING FORCES OF THE HUMAN BLOOD INDUSTRY
      • Table Geographical Distribution of RBC Demand by Region (United States, Europe, Japan, ROW), 2012
      • Table Projected World Demand for RBCs, 2012-2017
      • Table Worldwide Demand for RBCs for Acute and Chronic Conditions, 2012
      • Table Number of High Blood Loss Surgical Procedures by Type, 2012
      • Table Average Blood and Component Requirements by Condition
      • Variables Influencing the Demand for Blood Transfusions
      • Market Size
        • Table Global Blood Products Market by Type, Number of Units, Average Price and Total Value, 2012
        • Table Global Blood Collection and Transfusion Estimates (Millions of Units), 2012-2017
        • Table Global Plasma Collection and Transfusion Estimates , 2012-2017
    • CHANGING PATTERNS OF TRANSFUSION PROCEDURES
      • Leukocyte Reduction
      • Impact of Autologous Donations
      • Types of Autologous Donations
    • PRICING OF BLOOD
      • Table CMS Blood Product Reimbursement Rates, 2013
      • National Blood Exchange
      • RBCs and Leukoreduced RBCs
      • Washed Red Blood Cells
      • Deglycerolized Red Blood Cells
      • Single-Donor Platelets and Random-Donor Platelets
      • Fresh Frozen Plasma and Pooled Frozen Plasma
      • Cryoprecipitate
      • Granulocytes
      • Gamma-Irradiated Blood
    • AVERAGE COST OF TRANSFUSION
      • Table CMS Blood Transfusion Reimbursement Rates, 2013
    • PLASMA AND PLASMA DERIVED PRODUCTS
      • Plasma Market Size
        • Table Selected Plasma Derived Product Approvals, 2005 - 2012
        • Table The Global Market for Plasma and Plasma Derived Products, 2007 - 2017
      • Market Dynamics
        • Table Sales and Market Shares of Leading Suppliers of Plasma and Plasma Derived Products, 2012
      • Immunoglobulins
        • Table Global Market for Immunoglobulins by Manufacturer 2012 - 2017
      • Albumin
      • Prothrombin Complex Concentrates
        • Table Global Market for Human Albumin Products by Brand, 2012 - 2017
        • Table Prevalence of Conditions Requiring Prothrombin Complex Concentrates
      • Alpha-1 Proteinase Inhibitors
      • Fibrin Sealants
      • Clotting Factors and Factor VIIa
  • The Blood Testing and Typing Markets
    • BLOOD TESTING PRODUCTS FOR DONOR SCREENING
      • Market Size
        • Table Total Global Market for Immunoassay versus Nucleic Acid Testing Equipment: 2007 - 2017
      • Latin America
      • China
        • Table Global Blood Banking and Plasmapheresis Testing by Molecular Diagnostics: 2012 - 2017
        • Table U.S. Blood Banking and Plasmapheresis Testing by Molecular Diagnostics: 2012 - 2017
        • Table Global Projected Blood Banking and Plasmapheresis Molecular Diagnostics Testing Market Potential: 2012 - 2017
        • Table Projected Blood Banking and Plasmapheresis Molecular Diagnostics Testing Market Potential in the United States: 2012 - 2017
      • Market Participants
        • Table Selected Commercially Available Molecular (Nucleic Acid) Tests for Blood, Plasma and Organ Donor Screening in the United States, 2005 - 2012
    • BLOOD TYPING PRODUCTS
      • Market Size
      • Market Participants
    • PLASMA AND BLOOD COLLECTION EQUIPMENT
      • Market Size
        • Table Total Global Market for Blood Collection Equipment: 2007 - 2017
        • Table Global Market for Automated Blood Collection Equipment: 2007 - 2017
      • Market Participants
  • Synthetic Blood Products Market
    • DRIVING FORCES OF THE SYNTHETIC BLOOD PRODUCTS INDUSTRY
      • Variables Influencing the Supply and Demand of Donated Blood
    • RECOMBINANT FACTOR MARKET
      • Market Size
        • Table World Recombinant Factor Market by Brand, 2010 - 2017
      • Market Participants
    • OXYGEN CARRIER MARKET
      • Market Size
        • Table High Blood Loss Market HBOC and PFC Agent Revenues, 2012 - 2017
    • SYNTHETIC BLOOD PRODUCTS IN CLINICAL DEVELOPMENT
    • HEMOPURE (OPK BIOTECH)
      • Oxygent (Sanguine Corp.)
      • Oxycyte (Oxygen Biotherapeutics)
      • Perftoran (Perftoran)
      • PHER-O2 (Sanguine Corp.)
      • MP4OX (Sangart)
      • Advate (Baxter)
      • Recombinant Factors
        • Table Leading Recombinant Factor Products in Clinical Trials, 2013
      • Stem Cell Approaches
    • OTHER RESEARCH INITIATIVES
      • Jerome H. Holland Laboratory
      • Program in Cellular and Molecular Medicine
      • National Blood Foundation
  • Total Blood Products Market
    • THE BLOOD PRODUCTS INDUSTRY
      • Market Size
        • Table Global Blood Products Market Forecast by Segment, 2012 - 2017
  • Company Profiles
    • AABB
    • ABBOTT LABORATORIES
    • AMERICA'S BLOOD CENTERS
    • AMERICAN RED CROSS
    • BAXTER INTERNATIONAL
    • BIO-RAD LABORATORIES
    • BIOTIME INC.
    • GEN-PROBE INC. /HOLOGIC
    • FENWAL/FRESENIUS KABI
    • GRIFOLS BIOLOGICALS, INC.
    • NOVARTIS DIAGNOSTICS
    • NOVO NORDISK A/S
    • OPK BIOTECH
    • OXYGEN BIOTHERAPEUTICS
    • PERFTORAN
    • ROCHE
    • SANGUINE CORP.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report